Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori

Gut

Volumn 60, Issue 5, 2011, Pages 624-630

  Hagiwara, Tadashi ^a   Mukaisho, Ken Ichi ^a   Nakayama, Takahisa ^a   Sugihara, Hiroyuki ^a   Hattori, Takanori ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHIC GASTRITIS; CONTROLLED STUDY; DISEASE EXACERBATION; GERBIL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; LYMPHOCYTIC INFILTRATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH ANTRUM; STOMACH FUNDUS; STOMACH PARIETAL CELL; TISSUE SECTION; TREATMENT DURATION;

ADENOCARCINOMA; ANIMALS; BODY WEIGHT; COCARCINOGENESIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; GASTRINS; GASTRITIS, ATROPHIC; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MALE; METAPLASIA; PROTON PUMP INHIBITORS; STOMACH; STOMACH NEOPLASMS;

EID: 79953732352     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.207662     Document Type: Article

References (38)

1. Targownik LE, Metge CJ, Leung S, et al. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Gastroenterology 2008;134:937-44.
2. Hawkey CJ, Karrasch JA, Szczepañski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998;338:727-34. (Pubitemid 28115091)
3. Jalving M, Koornstra JJ, Wesseling J, et al. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther 2006;24:1341-8. (Pubitemid 44571564)
4. Stolte M. Fundic gland polyps: a rare, innocuous, and reversible disturbance. Gastroenterology 1993;105:1590-1. (Pubitemid 23315344)
5. Raghunath AS, O'Morain C, McLoughlin RC. Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 2005;22:55-63. (Pubitemid 41153080)
6. Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986;35:42-55. (Pubitemid 17197933)
7. Dawson R, Manson JM. Omeprazole in oesophageal reflux disease. Lancet 2000;356:1770-1.
8. Correa P. Chronic gastritis as a cancer precursor. Scand J Gastroenterol Suppl 1984;104:131-6. (Pubitemid 15191690)
9. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002;2:28-37. (Pubitemid 37328805)
10. Kuipers EJ, Uyterlinde AM, Peña AS, et al. Increase of Helicobacter pyloriassociated corpus gastritis during acid suppressive therapy: implications for longterm safety. Am J Gastroenterol 1995;90:1401-6.
11. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-22. (Pubitemid 26123777)
12. García Rodríguez LA, Lagergren J, Lindblad M. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut 2006;55:1538-44. (Pubitemid 44629198)
13. Kuipers EJ. Proton pump inhibitors and gastric neoplasia. Gut 2006;55;1217-21. (Pubitemid 44277346)
14. Viste A, Øvrebø K, Maartmann-Moe H, et al. Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. Gastric Cancer 2004;7:31-5.
15. Sundler F, Andersson K, Mattsson H, et al. Administration of omeprazole to rats for one year produces reciprocal effects on antral gastrin and somatostatin cells and no effect on endocrine cells in the colon. Digestion 1995;56:194-8.
16. Hagiwara T, Mukaisho K, Ling ZQ, et al. Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats. Dig Dis Sci 2007;52:1219-24. (Pubitemid 46626165)
17. Watanabe T, Tada M, Nagai H, et al. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998;115:642-8. (Pubitemid 28397299)
18. Kudo T, Lu H, Wu JY, et al. Pattern of transcription factor activation in Helicobacter pylori-infected Mongolian gerbils. Gastroenterology 2007;132:1024-38. (Pubitemid 46440871)
19. Franco AT, Israel DA, Washington MK, et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci USA 2005;102:10646-51. (Pubitemid 41061608)
20. Boivin GP, Washington K, Yang K, et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 2003;124:762-77. (Pubitemid 36268493)
21. Honda S, Fujioka T, Tokieda T, et al. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Research 1998;58:4255-9. (Pubitemid 28450020)
22. Zheng Q, Chen XY, Shi Y, et al. Development of gastric adenocarcinoma in Mongolian gerbils after long-term infection with Helicobacter pylori. J Gastroenterol Hepatol 2004;19:1192-8. (Pubitemid 39371264)
23. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402. (Pubitemid 30164342)
24. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003;124:1193-201. (Pubitemid 36531795)
25. Elfvin A, Bölin I, Von Bothmer C, et al. Helicobacter pylori induces gastritis and intestinal metaplasia but no gastric adenocarcinoma in Mongolian gerbils. Scand J Gastroenterol 2005;40:1313-20. (Pubitemid 41658730)
26. Orlando LA, Lenard L, Orlando RC. Chronic hypergastrinemia: causes and consequences. Dig Dis Sci 2007;52:2482-9. (Pubitemid 47373877)
27. Odenbreit S, Püls J, Sedlmaier B, et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000;287:1497-500. (Pubitemid 30127145)
28. Selbach M, Moese S, Hauck CR, et al. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 2002;277:6775-8. (Pubitemid 34953058)
29. Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002;295:683-6. (Pubitemid 34111828)
30. Amieva MR, Vogelmann R, Covacci A, et al. Disruption of the epithelial apical - junctional complex by Helicobacter pylori CagA. Science 2003;300:1430-4. (Pubitemid 36638162)
31. Schwentker V. The gerbil, a new laboratory animal. The Illinos Vet 1963;6:5-9.
32. Larsson H, Carlsson E, Hakanson R, et al. Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1988;95:1477-86.
33. Klinkenberg-Knol EC, Nelis F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety and influence on gastric mucosa. Gastroenterology 2000;118:661-9. (Pubitemid 30171615)
34. Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000;118:36-47. (Pubitemid 30020371)
35. Fox JG, Rogers AB, Ihrig M, et al. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 2003;63:942-50. (Pubitemid 36278423)
36. Hagiwara T, Mukaisho K, Ling ZQ, et al. Rebamipide contributes to reducing adverse effects of long-term administration of omeprazole in rats. Dig Dis Sci 2007;52:988-94. (Pubitemid 46481256)
37. Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, et al. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long-term omeprazole reverses gastritis without exacerbation of reflux disease; results of a randomised controlled trial. Gut 2004;53:12-20. (Pubitemid 38083004)
38. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81. (Pubitemid 46854190)